LY305
id:
ly305-190-17329184
title:
LY305
text:
LY305 is a transdermally bioavailable selective androgen receptor modulator (SARM) developed by Eli Lilly for the treatment of osteoporosis in men. Its chemical structure includes N-arylhydroxyalkyl. A phase one trial found promising results.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/LY305
date created:
date modified:
2024-01-31T20:58:59Z
main entity:
{"identifier":"Q27455402","url":"https://www.wikidata.org/entity/Q27455402"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/5b/LY305.svg","width":515,"height":290}
fields total:
13
integrity:
15